GoodRx Holdings Inc [GDRX] stock is trading at $7.07, up 7.45%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GDRX shares have gain 7.61% over the last week, with a monthly amount glided 10.82%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 14, March 2024, GoodRx Interim CEO Extends Commitment to Company. In a post published today on Yahoo Finance, Company Announces Board Resignations.
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on March 25, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $10 from $7.50. Previously, JP Morgan upgraded its rating to Overweight on March 01, 2024, and elevated its price target to $10. On February 26, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $8 on the stock. BofA Securities downgraded its rating to a Underperform and decreased its price target to $4.50 on January 02, 2024. DA Davidson upgraded its rating to a Buy but $9.50 remained the price target by the analyst firm on August 10, 2023. TD Cowen upgraded its rating to Outperform for this stock on July 31, 2023, and upped its price target to $12. In a note dated December 01, 2022, Citigroup initiated an Buy rating and provided a target price of $7 on this stock.
GoodRx Holdings Inc [GDRX] stock has fluctuated between $4.14 and $9.37 over the past year. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $7.07 at the most recent close of the market. An investor can expect a potential return of 147.52% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 750.26M for the trailing twelve months, which represents a growth of 6.81%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.77 points at the first support level, and at 6.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.65, and for the 2nd resistance point, it is at 8.23.
GoodRx Holdings Inc [GDRX] reported earnings per share of $0.08 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.07/share, meaning a difference of $0.01 and a surprise factor of 14.30%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.06 per share as compared to estimates of $0.06 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
For context, GoodRx Holdings Inc’s Current Ratio is 7.12. In addition, the Quick Ratio stands at 7.12 and the Cash Ratio stands at 5.49. Considering the valuation of this stock, the price to sales ratio is 3.72, the price to book ratio is 3.66.
Transactions by insiders
Recent insider trading involved Wagner Scott, that happened on Nov 30 ’23 when 21652.0 shares were purchased., Wagner Scott completed a deal on Nov 29 ’23 to buy 26348.0 shares. Meanwhile, Wagner Scott bought 4157.0 shares on Nov 28 ’23.
